Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Revenue

Intellia Therapeutics had revenue of $52.60M in the twelve months ending March 31, 2024, down -1.63% year-over-year. Revenue in the quarter ending March 31, 2024 was $28.94M with 129.53% year-over-year growth. In the year 2023, Intellia Therapeutics had annual revenue of $36.28M, a decrease of -30.40%.

• Revenue (ttm): $52.60M
• Revenue Growth: -1.63%
• P/S Ratio: 40.62
• Revenue / Employee: $100,008
• Employees: 526
• Market Cap: 2.14B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	36.28M	-15.85M	-30.40%
Dec 31, 2022	52.12M	19.07M	57.69%
Dec 31, 2021	33.05M	-24.94M	-43.01%
Dec 31, 2020	57.99M	14.89M	34.55%
Dec 31, 2019	43.10M	12.67M	41.63%
Dec 31, 2018	30.43M	4.32M	16.53%
Dec 31, 2017	26.12M	9.64M	58.49%
Dec 31, 2016	16.48M	10.44M	172.65%
Dec 31, 2015	6.04M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.